Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

18F-Florbetaben (FBB)

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · PHASE 2 TRIAL

Alzheimer's Disease Research Center (ADRC) PET Component Study

ClinicalTrials.gov

This is a Phase 2 interventional study still enrolling that has not yet reported results; it is designed to characterize PET imaging biomarkers in Alzheimer's disease progression but contains no outcome data.

PreliminaryNCT07758660 Dementia Patrick Lao

Reported

Planned enrollment120

Enrollment rate24 participants per year

Study duration5 years

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support